Is IR-Med, Inc. (IRME) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 143.0% / 30% | 117.5% / 30% | 49.2% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 143.0% / 33% | 117.5% / 33% | 49.2% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 62.5% / 33% | 51.4% / 33% | 21.5% / 33% | N/A | ✗ NOT HALAL |
| S&P | 143.0% / 33% | 117.5% / 33% | 49.2% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 62.5% / 33% | 51.4% / 33% | 21.5% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Assets (ROA) | -172.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$1M |
| Free Cash Flow | -$1M |
| Total Debt | $157,000 |
| Current Ratio | 0.1 |
| Total Assets | $251,000 |
Price & Trading
| Last Close | $0.01 |
| 50-Day MA | $0.00 |
| 200-Day MA | $0.03 |
| Avg Volume | 9K |
| Beta | 2.8 |
|
52-Week Range
$0.00
| |
About IR-Med, Inc. (IRME)
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is IR-Med, Inc. (IRME) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), IR-Med, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is IR-Med, Inc.'s debt ratio?
IR-Med, Inc.'s debt ratio is 143.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 62.5%.
What are IR-Med, Inc.'s key financial metrics?
IR-Med, Inc. has a market capitalization of $560,031.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.